Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

alpha2-Macroglobulin and haptoglobin suppress amyloid formation by interacting with prefibrillar protein species.

Yerbury JJ, Kumita JR, Meehan S, Dobson CM, Wilson MR.

J Biol Chem. 2009 Feb 13;284(7):4246-54. doi: 10.1074/jbc.M807242200.

PMID:
19074141
2.

Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.

Nguyen P, Derreumaux P.

Acc Chem Res. 2014 Feb 18;47(2):603-11. doi: 10.1021/ar4002075. Review.

PMID:
24368046
3.

Plasticity of amyloid fibrils.

Wetzel R, Shivaprasad S, Williams AD.

Biochemistry. 2007 Jan 9;46(1):1-10. Review.

4.

Toward a molecular theory of early and late events in monomer to amyloid fibril formation.

Straub JE, Thirumalai D.

Annu Rev Phys Chem. 2011;62:437-63. doi: 10.1146/annurev-physchem-032210-103526. Review.

PMID:
21219143
5.

Trapping of human hemoglobin by haptoglobin: molecular mechanisms and clinical applications.

Ratanasopa K, Chakane S, Ilyas M, Nantasenamat C, Bulow L.

Antioxid Redox Signal. 2013 Jun 10;18(17):2364-74. doi: 10.1089/ars.2012.4878. Review.

PMID:
22900934
6.

In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.

Benseny-Cases N, Klementieva O, Cladera J.

Subcell Biochem. 2012;65:53-74. doi: 10.1007/978-94-007-5416-4_3. Review.

PMID:
23224999
7.

alpha2-macroglobulin in late-onset Alzheimer's disease.

Kovacs DM.

Exp Gerontol. 2000 Jul;35(4):473-9. Review.

PMID:
10959035
Items per page

Supplemental Content

Support Center